AUBHO2016 Scientific Agenda
Venue: NAI LERT PARK SWISSOTEL BALLROOM (BASEMENT)
AUGUST 25: Asia HaploTransplant Symposium (CLICK HERE)
AUGUST 26: AUBHO2016 Plenary Joint Session
AUGUST 27: AUBHO2016 Parallel Sessions: Hematology and Solid Tumor
AUBHO2016: Principles and Application of Immunotherapy in Cancer
Plenary-Joint Session Day 1 (AUGUST 26, 2016)
8: 00 AM Welcome and introduction
Moderator: Surapol Issaragrisil; Borje Andersson; Thiravud Khuhaprema
Immunotherapy and Cancer
Moderator: Nuchanan Areethamsirikul and Vikram Mathews
8:20 AM Personalized Medicine Approach to Cancer
Apostolia Maria Tsimberidou, USA
8:45 AM Modulation of T cell response: PI3K-Akt pathway; PD-1 Pathway and CTLA4 pathway
Frederick Hagemeister, USA
9:20 AM BiTE Therapy
Didier Blaise, France
9:45 AM Cancer Immunology for the Non-Immunologist
Nina Shah
10: 00 AM: Coffee Break
Cell Therapy
Moderator: Meng Lv and Govind Babu
10:20 AM: CAR-T cells and its applications
Keiya Ozawa, Japan
10:45 AM NK Cell therapy platform and its applications
Nina Shah, USA
11:00 AM Monitoring Adoptive Cellular Therapies
David Ritchie, Australia
11:15 AM: Health-related quality of life in patients with CML after transplant
Qian Jiang, China
Kian Ang Memorial Lecture
Moderator: Borje Andersson and Xiang-Yu Zhao
11:30 AM The many non-transplant application of cord blood
Young-Ho Lee, S. Korea
Moderator: Nuchanan Areethamsirikul and Vikram Mathews
8:20 AM Personalized Medicine Approach to Cancer
Apostolia Maria Tsimberidou, USA
8:45 AM Modulation of T cell response: PI3K-Akt pathway; PD-1 Pathway and CTLA4 pathway
Frederick Hagemeister, USA
9:20 AM BiTE Therapy
Didier Blaise, France
9:45 AM Cancer Immunology for the Non-Immunologist
Nina Shah
10: 00 AM: Coffee Break
Cell Therapy
Moderator: Meng Lv and Govind Babu
10:20 AM: CAR-T cells and its applications
Keiya Ozawa, Japan
10:45 AM NK Cell therapy platform and its applications
Nina Shah, USA
11:00 AM Monitoring Adoptive Cellular Therapies
David Ritchie, Australia
11:15 AM: Health-related quality of life in patients with CML after transplant
Qian Jiang, China
Kian Ang Memorial Lecture
Moderator: Borje Andersson and Xiang-Yu Zhao
11:30 AM The many non-transplant application of cord blood
Young-Ho Lee, S. Korea
12:00 PM Lunch
12:30 PM (Simultaneous Sessions)
12:30 PM (Simultaneous Sessions)
|
Myeloma Spotlight Session
Moderator: Raymond Wong and Nina Shah Case Presentation 1: Newly diagnosed patient with IGA Lambda Myeloma and R-ISS III (chromosome 13 deletion) Nina Shah and Raymond Wong Objective 1. To understand the practice pattern of the APAC-based oncologists for treating high risk myeloma patients 2. To understand diagnostic tools utilized for risk stratification for newly diagnosed myeloma Case Presentation 2: Relapsed patient at 6 months post last treatment Ming Yao and Govind Babu Objective 1. To understand differences in the therapeutic choices at diagnosis and relapse 2. To understand sequencing of therapy 3. Identify triggering of therapy based on biochemical relapse versus symptomatic relapse 4. Examine the role of comorbidities on therapeutic choices 5. Identify therapy choices based on side effects like neuropathy and renal insufficiency Case Presentation 3: Newly diagnosed patient for transplant consultation Chutima Kunacheewa and David Ritchie Objective 1. To understand timing of autologous stem cell transplant 2. Discuss the role of stringent CR, delayed transplant, harvest and hold 3. To understand therapy choice for maintenance |
Solid Tumor: Best Abstract Session
Moderator: Surachat Chakrapeesirisuk Top 10 Abstracts from international meetings Immunotherapy (3):Rachna Shroff GU cancer (2): Jay Shah TBA (4): Pongwut Danchaivijitr |
2:00 PM Simultaneous Sessions
|
2:00 PM
Multiple Myeloma Moderator: Pankaj Malhotra and Piyanuch Kongtim - Tumor Infiltrating Lymphocytes Raymond Wong - Cell therapy Nina Shah - Monoclonal antibodies Govind Babu |
2:00 PM
Solid Tumor Moderator: Vichien Srimuninnimitr and Charuwan Akewanlop - Targeted therapy for Hepatocellular and Cholangiocarcinoma Rachna Shroff - Immunotherapy and novel targets for advanced cancers Apostolia Maria Tsimberidou - Immunotherapy for Prostate Cancer Jay Shah-Immunotherapy for Breast Cancer Ashok Vaid |
4:00 PM ADJOURN
AUBHO2016: Principles and Application of Immunotherapy in Cancer
Parallel Session DAY 2 (August 27, 2016)
|
Hematologic Malignancies
8:00 AM Moderator: Surapol Issaragrisil and Nina Shah Top 10 Abstracts from international meetings Lymphoma: Frederick Hagemeister Leukemia: Didier Blaise Myeloma: Nuchanan Areethamsirikul 10:00 AM COFFEE BREAK
10: 30 AM
Hematology Moderator: Kaiyan Liu and Didier Blaise - FLT3 targeted therapy Simrit Parmar - NK cell therapy for AML Stefan Ciurea - Targeted therapy for APL Meng Lv - CAR-T cell therapy for Lymphoma Simrit Parmar 12:00 PM ADJOURN
|
Solid Tumor
9:00 AM Moderator: Suthinee Ithimakin and Pongwut Danchaivijitr - Prospective trials in precision medicine Apostolia Maria Tsimberidou - Targeted Therapy for Bladder Cancer Jay Shah 10:00 AM COFFEE BREAK
10:30 AM SPECIAL SESSION
Fundamentals OF Immunotherapeutics for Lung Cancer 12:00 PM BREAST CANCER SESSION
-Novel targets: triple negative Breast Cancer
Banu Arun Breast Cancer Case Presentation
Moderator: Banu Arun and Surachat Chakrapeesirisuk Case Presentation 1: Newly diagnosed locally advanced Her-2/neu positive breast cancer Objective 1. To understand indications for neoadjuvant chemotherapy 2. To understand neoadjuvant therapy options for Her-/neu positive breast cancer Case Presentation 2: Patient with metastatic triple negative breast cancer Objective 1. To understand treatment options for stage 4 TNBC 2. To understand indications for germline hereditary breast cancer gene testing Case Presentation 3: 34 year old premenopausal women with stage 1 breast cancer Objective 1. To understand indications for endocrine therapy 2. To understand type of endocrine therapy |